Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    22169620 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Vitamin K2 Supplementation to Activate Matrix Gla Protein (MGP) as Endogenous Inhibitor of Vascular Calcification in Hemodialysis Patients
Condition: CKD 5D, Hemodialysis
Intervention: Dietary Supplement: daily supplementation of MK-7 over 6 weeks

Indicates status has not been verified in more than two years